Can we predict the risk factors for switching due to ineffectiveness in the first year of therapy with bDMARD in patients with rheumatoid arthritis? Ana Martins; Sofia Pimenta; Daniela Oliveira; Rafaela Nicolau; Alexandra Bernardo; Teresa Martins Rocha; Lúcia Costa; Miguel Bernardes;

Raoul Dufy: Color and resilience in the fight against rheumatoid arthritis Fernando Canillas; Marta Canillas;

Agreement between cardiovascular risk scores in a high-altitude Andean population with rheumatoid arthritis Carlos Diaz-Arocutipa; Vidia Lumbe-Diaz; Percy Soto-Becerra;